What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Established that the excessive accumulation of brain neuromelanin cause the Parkinson's disease With gene therapy they managed to reduce the intracellular neuromelanin levels below the pathological threshold thus preventing the appearance of symptomatology and neurodegeneration. News Vall d'Hebron leads the first International Vaccination Guide for human papilloma virus in high risk populations Recommendations based on different levels of evidence based on the risk of infection and pathology associated with HPV in the risk groups and also based on the available evidence on vaccines. News The Michael J. Fox Foundation will finance a research project on new drugs for Parkinson's disease The Michael J Fox Foundation for Parkinson's Research Foundation (MJFF) and the Silverstein Foundation for Parkinson's disease with GBA will fund a research project led by Dr. Marta Martínez from the VHIR. News A gene involved in ADHD could be related to addictive substance use The gene LPHN3, a genetic factor related to the attention deficit / hyperactivity disorder (ADHD) in kids and adults, is associated -for the first time- with a high risk of consuming addictive substances. News Vall d’Hebron is the first center of the State that successfully treats a patient in the presymptomatic phase of infantile spinal muscle atrophy Vall d'Hebron professionals have also participated in trials that have allowed the development of this innovative gene therapy News Brown adipose tissue could be a therapeutic target to treat type 2 diabetes and obesity The study shows that the MTERF4 protein is essential for mitochondrial function in brown adipose tissue. News The Comik program of personalized medicine in pediatric cancer in Vall d'Hebron has benefited more than 40 children and adolescents The professionals analyze the tumor of each patient to obtain their molecular signature, which can allow the use of personalized treatments based on the anomalies detected. News Pre-registration for the 6th edition of the Master in Translational Biomedical Research of the VHIR The pre-registration period for the 2019-2020 academic year of the Master's Degree in Translational Biomedical Research of the Vall d'Hebron Institute of Research (VHIR) will be open from February 12 to September 10, 2019, or until the curs fills up. News Vall d'Hebron and the National Art Museum of Catalonia come together to promote new treatments through art This collaboration agreement will begin with a project aimed at studying new art health therapies in the field of psychology. News A study confirms the validity of the ROX index to determine the need to intubate a patient with acute respiratory failure treated with high-flow oxygen therapy Researchers have defined a predictor of success or failure to detect which patients will respond positively to therapy and not delay intubation in those who will not. News Antibiotics can become a new weapon against cancer by decreasing tumor growth Researchers from VHIR have shown for the first time in vivo that bactericidal antibiotics in combination with autophagy blockers decrease tumor growth. News The oncological research of the VHIR united in the World Cancer Day This morning, researchers from all the VHIR research groups belonging to the Oncology area gathered at the doors of the Collserola building to show their fight against cancer through research. News A study recommends reconsidering Hepatitis A vaccination protocol to prevent a vaccine-resistant virus Researchers have analyzed the evolution of hepatitis A virus in vaccinated and unvaccinated patients with massive sequencing techniques. News Vall d'Hebron launches a campaign to promote the research for children's heart diseases The campaign #VHTocaElCor aims to raise awareness about the importance of childhood heart diseases and promote research in this field. News One study determines the mortality and predictors of long-term survival of patients with chronic hypersensitivity pneumonitis Patients with chronic hypersensitivity pneumonitis (CHN) live an average of 7 years. News The Easysims innovation project of VHIR selected to receive the support of CIMTI Easysims becomes the second project of the VHIR selected to receive support from CIMIT in the two years of operation of this initiative created in 2017. News Genetic predisposition favors cannabis use in people with ADHD People with ADHD are almost eight times more likely to use cannabis throughout their lives. The study has described four shared genetic regions in both disorders. The prevalence rate of substance use disorder in adult ADHD is 45%. News The Association Llavaneres Contra el Càncer hands €10.000 for the research at childish sarcomas Peromissi The Association Llavaneres Contra el Càncer organized several acts to collect money and fund with it the VHIRs' research on new therapies for the childish sacormas. News Dr. Rosa Burgos receives a Sanitat Baix Llobregat Award from the College of Physicians of Barcelona The awards reward research aimed at improving the effectiveness and efficiency of health services. News Dr. Maria Buti, among world's most cited researchers In its list of the world's most cited researchers, Clarivate Analytics includes Dr. Maria Buti, principal investigator of the Liver Diseases research group at VHIR. Pagination First page « Previous page ‹ … Page 74 Page 75 Current page 76 Page 77 Page 78 … Next page › Last page »
